Aurobindo Pharma Limited (AUROPHARMA.BO)

1.238,90 +26,05 (+2,15%) A partir del 02:08PM IST. Mercado abierto.

Aurobindo Pharma Limited

Galaxy, Plot No. 1
22nd-24th Floor Plot No.1, Survey No.83/1 Hyderabad Knowledge City,Raidurg Panmakt
Hyderabad 500032
India
91 40 6672 5000
https://www.aurobindo.com

Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Kambam Nityananda Reddy	Vice Chairman & MD	37,41M	N/A	1958
Mr. Mettu Madan Mohan Reddy	Whole-Time Director	52,35M	N/A	1960
Mr. Santhanam Subramanian	Chief Financial Officer	21,06M	N/A	1961
Mr. Sanjeev Indravadan Dani	COO & Head of Formulations	N/A	N/A	1960
Dr. S. Vijaya Kumar	President of Technical	N/A	N/A	1966
Mr. Arvind Bothra	Head of Investor Relations & Corporate Communications	N/A	N/A	N/A
Mr. B. Adi Reddy	Compliance Officer & Company Secretary	4,76M	N/A	N/A
Mr. G. P. Prasad	Senior Vice President of Global Finance & Operations	N/A	N/A	N/A
Dr. Sudhir Bimal Singhi	Head of Global Finance Operations	N/A	N/A	1969
Dr. A. Rama Mohana Rao	President of Corporate QA	N/A	N/A	1962

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en INR.

Descripción

Aurobindo Pharma Limited engages in manufacturing of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, and internationally. It offers formulation in form of orals, injectables and over-the-counter drugs; and active pharmaceutical ingredients (API) for biosimilars, dermatology, respiratory, vaccines, and peptides, as well as oncology, hormones, and sterile products. The company also provides antiretroviral drugs for the people and children living with HIV; and AuroZymes, a biocatalysts product for use in the pharmaceutical and chemical industries. In addition, it offers AuroSource, a contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for penicillin's, cephalosporins, and non beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Gobierno corporativo

El ISS Governance QualityScore de Aurobindo Pharma Limited, a día 1 de julio de 2024, es 1. Las puntuaciones base son Auditoría: 6; Tablero: 2; Derechos de los accionistas: 1; Compensación: 1.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.